Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 245

Showing 1-25 of 245 citing articles:

Nanomaterials for bone metastasis
Xinyan Hao, Buchan Jiang, Junyong Wu, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 640-651
Closed Access | Times Cited: 36
Leveraging Aptamer-Based DNA Nanotechnology for Bioanalysis and Cancer Therapeutics
Zhiyong Huang, Dan Wang, Qiang Zhang, et al.
Accounts of Materials Research (2024) Vol. 5, Iss. 4, pp. 438-452
Open Access | Times Cited: 32
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 20
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47
Liyang Hu, Weitao Zhuang, Mao-jian Chen, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1186-1200
Closed Access | Times Cited: 17
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
PD-L1 peptides in cancer immunoimaging and immunotherapy
Shiye Du, Junzhi Liu, Youjia Zhang, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1061-1079
Closed Access | Times Cited: 2
AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity
Anirudh Sivakumar, Hathaichanok Phuengkham, Hitha Rajesh, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
In Situ Formed Microalgae-Integrated Living Hydrogel for Enhanced Tumor Starvation Therapy and Immunotherapy through Photosynthetic Oxygenation
Cheng Zhang, Ziyi Han, Kewei Chen, et al.
Nano Letters (2024) Vol. 24, Iss. 12, pp. 3801-3810
Closed Access | Times Cited: 11
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 11
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer
Hongtao Song, Tong Lü, Donghui Han, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3728-3742
Open Access | Times Cited: 11
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 11
Salmonella-mediated methionine deprivation drives immune activation and enhances immune checkpoint blockade therapy in melanoma
Sujin Zhou, Shiwei Zhang, Kexin Zheng, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008238-e008238
Open Access | Times Cited: 10
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 9
Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics
Xiaohong Li, Yuting Wei, Zhirang Zhang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 1, pp. 44-63
Open Access | Times Cited: 8
Advancements in Colorectal Cancer Immunotherapy: From CAR-T Cells to Exosome-Based Therapies
Sepideh Arabi, Manouchehr Fadaee, Tohid Kazemi, et al.
Journal of drug targeting (2025), pp. 1-23
Closed Access | Times Cited: 1
Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic cervical cancer-on-a-chip model
Seth‐Frerich Fobian, Mohamadreza Amin, Andrea Sacchetti, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 236-250
Open Access | Times Cited: 1
Deciphering functional tumor-immune crosstalk through highly multiplexed imaging and deep visual proteomics
Xiang Zheng, Andreas Mund, Matthias Mann
Molecular Cell (2025)
Open Access | Times Cited: 1
Immune regulatory genes impact the hot/cold tumor microenvironment, affecting cancer treatment and patient outcomes
Mengmeng Sang, Jia Ge, Juan Ge, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, M Nagarajan, Irene Kang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 50-50
Open Access | Times Cited: 1
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma
Raphael Lutz, Alexandra M. Poos, Llorenç Solé‐Boldo, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Open Access | Times Cited: 1
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
Margherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Immunoregulatory role of exosomal circRNAs in the tumor microenvironment
Changsheng Lv, Jinhao Chen, Yuxiang Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Microenvironment-based immunotherapy in oral cancer: a comprehensive review
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Masumeh Ghazanfarpour, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top